SAM
KNSA icon

Smartleaf Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Smartleaf Asset Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.4K Hold
887
– – ﹤0.01% 1465
2026
Q1 		$40.5K Sell
887
-2
-0.2% -$89 ﹤0.01% 1570
2025
Q4 		$36.4K Buy
+889
New +$35.7K ﹤0.01% 1702
2025
Q1 		– Sell
-214
Closed -$4.19K – 2940
2024
Q4 		$4.19K Buy
+214
New +$4.88K ﹤0.01% 2309

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Smartleaf Asset Management's KNSA Position: Q2 2026 in Review

Smartleaf Asset Management held its Kiniksa Pharmaceuticals (KNSA) position steady in Q2 2026 at 887 shares worth $55.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1465.

Smartleaf Asset Management first reported a position in KNSA in Q4 2024 and has held it in 4 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Smartleaf Asset Management held 887 shares of Kiniksa Pharmaceuticals worth $55.4K as of Q2 2026.
  • Smartleaf Asset Management left its Kiniksa Pharmaceuticals share count unchanged in Q2 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1465 holding.
  • Smartleaf Asset Management first reported a position in Kiniksa Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.